Edaravone is a drug used worldwide for the treatment of Amyotrophic Lateral Sclerosis (ALS). The drug can be useful also to support cancer treatments.

Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers, International Immunopharmacology (2019).

Read: https://doi.org/10.1016/j.intimp.2019.105967

Categories: News